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Abstract
Objectives: Many studies of cancer worry use items measuring frequency or intensity. Little is known about how each of these
relate to cancer screening uptake. This study compared the association between worry frequency vs. intensity and colorectal
cancer screening intention/uptake.
Methods: Across four surveys (2014–2016), we collected data from 2878 screening-eligible men and women (aged 60–70) in
England. Measures included single-items assessing cancer worry frequency and intensity, and a derived combination of both. We
also assessed self-reported past faecal occult blood testing uptake (ever vs. never), intention to participate when next invited
(yes vs. no), and demographics. Using logistic regression, we compared a model containing sociodemographic characteristics
(Model 1), with four models adding cancer worry frequency (Model 2), intensity (Model 3), both (Model 4), or the combined
measure (Model 5).
Results: A model with cancer worry intensity and demographics (Model 3) explained significantly more variance in uptake and
intention (R2¼ 0.068 and 0.062, respectively) than demographics alone (Model 1: R2¼ 0.058 and 0.042; p< 0.001), or a model
with demographics and cancer worry frequency (Model 2: R2¼ 0.059 and 0.052; p< 0.001). The model was also equally as
effective as models including both the frequency and intensity items (Model 4: R2¼ 0.070 n.s. and 0.062 n.s.), or using the
derived combination of both (Model 5: R2¼ 0.063 n.s. and 0.053 n.s.).
Conclusion: A single item measure of cancer worry intensity appeared to be most parsimonious for explaining variance in
colorectal cancer screening intention and uptake.
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Introduction
Colorectal cancer (CRC), the fourth most common cancer
worldwide, accounts for 8.5% of all cancer mortality.1 In
the UK, nearly 35,000 new cases are diagnosed annually,
and CRC accounts for 10% of all cancer deaths.2
Population-based screening using the faecal occult blood
test (FOBt) can contribute to reducing the relative risk of
CRC mortality by up to 25% in those completing at least
one round of screening.3 Since 2006, the Bowel Cancer
Screening Programme (BCSP) in England has invited
men and women aged 60–69 to undertake free, home-
based biennial FOBt screening for colorectal cancer (this
programme has since been extended to age 74). Uptake
is sub-optimal (56% in 2015–16), with known socio-
demographic variation (particularly lower uptake among
ethnic minorities and individuals living in poorer areas4–7),
and effects of practical and psychological factors.6 One
such psychological factor is cancer worry, a negative emo-
tional reaction to the threat of cancer,8 shown to be higher
in women, those who are younger, and those from lower
socioeconomic or ethnic minority backgrounds.9,10
The effect of cancer worry on CRC screening uptake is
uncertain. Some studies have found a positive associa-
tion,11–13 others a negative association,14,15 some both
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positive and negative associations when considering differ-
ent facets of cancer worry,5,16–18 and others finding no
effect.19–24 Comparison between studies is hindered by
inconsistencies in how cancer worry is operational-
ized.8,25,26 Although studies should ideally include compre-
hensive measures of cancer worry, few have the capacity to
include detailed measures. Due to space restrictions, most
large population-based studies can only measure general
worry about cancer, without further specification of the
object of the worry. When measuring general cancer
worry, some studies operationalize it in terms of the
frequency of fearful thoughts about cancer, while others
measure the intensity of fearful thoughts about cancer. In
our view, cancer worry frequency and intensity are two
different, yet correlated, dimensions of cancer worry, on
which people may score differently. For example, someone
may feel very anxious when they think about cancer (high
intensity of cancer worry), and therefore try to avoid
thinking about it (low frequency), suggestive of an avoi-
dant coping style for cancer risk. Indeed, a study of under-
utilizers of breast cancer screening27 found that women
who were not planning to have a mammogram tended to
be “not at all” worried about breast cancer, yet also tended
to agree that they were “so fearful of cancer that you don’t
want to know if you have cancer or not”.
The idea of cancer worry as a function of both frequen-
cy and intensity of cancer worry is not new. Scales of fear
of cancer recurrence often include both,28 and clinical anx-
iety disorders are also characterized in terms of being
excessive (intensity) or persistent (frequency, duration)
compared with normative fear or anxiety (leading to clin-
ically important distress or impairment in functioning,
unlike cancer worry in the general population as here
described29). However, most population-based surveys of
cancer worry include only one of these dimensions, so it is
difficult to establish whether different associations with
behavioural outcomes found across studies are due to dif-
ferences in measurement or to real differences in the
behavioural correlates of cancer worry frequency
versus intensity.
To our knowledge, only three large population-based
studies have simultaneously included items that can be
considered as measures of cancer worry frequency and
cancer worry intensity to examine associations with
uptake of CRC screening,16–18 and thus allow comparisons
between these two measures and their association with
cancer screening behaviour. Using data from the US
Health Information National Trends Survey (HINTS),
McQueen et al.16 did not find an association between
cancer worry frequency (i.e. “How often do you worry
about getting colon cancer?”) and uptake of FOBt or
endoscopic screening. However, being afraid of finding
cancer, if tested (i.e. agreeing to the statement “You are
afraid of finding colon cancer if you were checked”), was
associated with a higher likelihood of endoscopic screening
in women, and also seemed to be associated with higher
uptake of FOBt, although this did not reach statistical
significance. Wong et al.18 used similar measures of
cancer worry frequency (i.e. (dis)agreement with the state-
ment “I never worry about getting CRC”) and fear
of finding cancer (i.e. “I am afraid of finding out if
I have CRC”) in a population-representative survey in
Singapore to examine associations with CRC screening
uptake (either FOBT or endoscopic screening, although
FOBt was reportedly used most often as test modality).
Their findings showed that more frequent worry about
getting CRC was associated with higher uptake of screen-
ing, while fear of finding out about CRC was associated
with lower uptake.18 Finally, in a prospective study of
flexible sigmoidoscopy (FS) screening in the UK, Vrinten
et al.17 found that worrying a lot about cancer (i.e. agree-
ment with the statement “I worry a lot about cancer”) was
associated with a higher likelihood of intending to attend
screening, but did not predict actual attendance, while feel-
ing uncomfortable when thinking about cancer (i.e.
“It makes me uncomfortable to think about cancer”)
was associated with a lower likelihood of attending FS
screening.17 These mixed findings suggest that there may
be differences between cancer worry frequency and inten-
sity measures and their relationship with screening inten-
tions and uptake, although the study samples were very
different and no firm conclusions can therefore be drawn
from these previous findings. In addition, these studies
only reported the behavioural associations for items sepa-
rately, and did not examine whether the behavioural asso-
ciations of cancer worry are even stronger for a combined
index of frequency and intensity of cancer worry, as may
be hypothesized based on the characterization of clinically
relevant anxiety as described above.
To better understand how cancer worry can best be
measured in population-based studies that seek to examine
the association of cancer worry with cancer-related behav-
ioural outcomes, this study compared measures of cancer
worry frequency, cancer worry intensity and a combina-
tion of both, and their association with intention and
uptake of the FOBT in a population-based sample of
screening-eligible English adults aged 60–70.
Methods
Design
We combined data from all four waves of the Attitudes,
Behaviour and Cancer UK Survey (Attitudes, Behaviour
and Cancer UK Survey [ABACUS]; 2014–2016), which
were collected by TNS Research International as part of
their weekly omnibus survey using face-to-face, computer-
assisted personal interviews. The TNS omnibus survey
defines sample points using 2001 Census small-area statis-
tics and the Postcode Address File (stratified by social
grade and Government Office Region), which are used
for random location sampling. To ensure a population-
representative sample, quotas are set for age, sex, children
in the home, and working status, and weights are provided
by the survey company. An adjustment weight was
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assigned to each case during analysis, so that respondents
with characteristics (age, sex, social grade, region) who
were underrepresented (relative to the national popula-
tion) were given a higher weight (>1) than those
who were relatively overrepresented (weight <1). The
ABACUS survey is a series of four population-based sur-
veys designed to assess attitudes to cancer and cancer
screening in England from 2014 to 2016. The first (2014;
N¼ 1675) focused mainly on colorectal cancer screening
using FOBt and included men and women aged 58–70.
The second (2015; N¼ 1464) focused on colorectal
cancer screening using FOBt and FS and included a
wider age range (men and women aged 50–70), while the
third (N¼ 2111) and fourth surveys (N¼ 2048; both col-
lected in 2016) focused on various beliefs and attitudes
about cancer in the general population, and included
men and women aged 18–70. The upper age limit for the
survey was chosen because this is the age at which people
tend to stop being invited to cancer screening in England;
the extension of the colorectal cancer screening pro-
gramme to age 74 had not been fully rolled out across
England at the time of the surveys. Several other papers
have been published from these datasets, including some
that examine different objects of cancer worry (e.g. fear of
death) in relation to cancer screening (ABACUS wave
3),10,30 but this is the first time that we have combined
all four datasets to obtain a large enough sample to exam-
ine the role of cancer worry frequency and intensity on
colorectal cancer screening uptake. All respondents resid-
ed in England at the time of the interview.
Participants
The sample for these analyses consisted of 2878 men and
women aged 60–70. We excluded participants who were
outside this age range and those who had a previous diag-
nosis of cancer. All participants consented at the start of
the interview.
Measures
Sociodemographics, including the respondents’ age,
gender, ethnicity, marital status, and social grade were
recorded using simple questions. Ethnicity was measured
using 16 categories from the UK Census,31 but were
dichotomized into White vs. non-White (including mixed
ethnic backgrounds) due to small numbers in the ethnic
minority groups. Marital status was recorded as “married
or living as married,” “single,” and “widowed, separated,
or divorced.” Social grade was used as an indicator of
socioeconomic status and was recorded using the catego-
ries from the National Readership Survey.32 These are
based on the occupation of the chief wage earner in each
household. The categories were: A (higher managerial,
administrative, or professional), B (intermediate manage-
rial, administrative, or professional), C1 (supervisory, cler-
ical or junior managerial, administrative, or professional),
C2 (skilled manual), D (semiskilled or unskilled manual),
or E (state pensioners, casual/lowest grade workers, or
unemployed with state benefits only). Grades A and B
were combined to create more equal sized groups, as
were groups D and E.
Cancer worry was assessed with two items, one assess-
ing cancer worry frequency and one assessing cancer worry
intensity. These questions were the same across all four
surveys. Cancer worry frequency was measured with the
item: ‘How often do you worry about your chance of get-
ting cancer yourself?’, with response options ‘never’, ‘occa-
sionally’, ‘sometimes’, ‘often’, and ‘very often’, which was
adapted from the US HINTS.33 Cancer worry intensity
was measured with the item: ‘How anxious do you feel
when you think about cancer?’, with response options
‘not at all’, ‘slightly’, ‘quite a bit’, and ‘extremely’. The
two items were significantly correlated (rs[2632]¼ 0.573,
p< 0.001). It should be noted that these items are about
cancer in general, and are not specific to colorectal cancer.
In addition, we combined these two items to create a con-
ceptual categorization of cancer worry. In accordance with
accepted definitions of clinically relevant anxiety, which
differentiates anxiety disorders from developmentally nor-
mative fear as being “excessive or persisting beyond devel-
opmentally appropriate periods”29 (i.e. as a function of
intensity or frequency/duration of the anxiety), we concep-
tualized high cancer worry as worry that was very high in
intensity, or very frequent. Consistent with some of our
previous studies,34,35 we categorized this combined mea-
sure in three levels: “no cancer worry” (those who “never”
worried and were “not at all” anxious), moderate cancer
worry (those who worried “occasionally” or “sometimes”,
or who were “slightly anxious”), and high cancer worry
(those who worried “often” or “very often”, or who were
“quite a bit” or “extremely” anxious). We have favoured a
conceptual categorization in three categories (to allow for
exploration of curvilinear effects) rather than combining
the two items by adding or averaging the scores, because
scores in the middle of the range for sum or average scores
may be difficult to interpret. For example, they could
result from scores in the middle of the range for both
items, or from scores at the top end of the range for one
item and the bottom end of the range for the other item.
Conceptually, these two scenarios are very different from
each other, and we have therefore favoured a conceptual
classification, whereby high scores on either (or both) item
(s) would always result in being classified as being ‘high’ in
cancer worry, while only scoring the lowest score on both
items (‘not at all anxious’ and ‘never worried’) results in
being classified as having ‘no’ cancer worry.
Intentions to do the FOB test in the future were
assessed in all surveys using variations of the same ques-
tion: “Will you do the stool test when you are next sent
one/the next time you are sent a kit/the next time you are
invited?” Response options were the same for all versions
of this question, and consisted of “definitely not,”
“probably not,” “yes, probably,” “yes, definitely,” which
were categorized as ‘not intending to complete FOBt
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screening’ (“definitely not” and “probably not”) and
‘intending to complete FOBt screening’ (“yes, probably”
and “yes, definitely”). “Don’t know/not sure” responses
were coded as missing.
Self-reported screening uptake among screening-eligible
respondents was recorded slightly differently in the four
waves of the ABACUS survey, but for the purpose of this
study, all responses were dichotomized as ‘never’ (as in
never having returned one of the routine colorectal
cancer screening test kits sent by the National Health
Service BCSP) vs. ‘ever’ screening (i.e. having returned at
least one test kit). In survey 1, respondents were asked
whether they had ever been invited to do a stool test for
the National Health Service BCSP. Respondents answer-
ing ‘yes’, were asked additional questions about how many
times they had received a stool kit and how many times
they had taken part. All participants who indicated that
they had done at least one test kit were coded as ‘ever’
having participated. In survey 2, respondents were asked,
‘Have you ever done the stool test?’ (yes, no, don’t know),
with ‘yes’ responses coded as ‘ever’ (1) and ‘no’ responses
coded as ‘never’ (0). In surveys 3 and 4, respondents were
asked which of five statements best described them. The
statements were based on the stages of the Precaution
Adoption Process Model36 and were dichotomized to
characterize ‘never’ participants as those who were eligible
for FOBt screening but reported never having heard of it,
never having been invited, or never having done it, and
‘ever’ participants as those who reported having completed
the test at least once. Respondents stating ‘don’t know’ or
‘refused’ were coded as missing. A previous study has
shown that self-reported ever uptake of screening is
highly reliable.37
We excluded those with missing data on the cancer
worry, intention, and self-reported uptake variables. We
report descriptive statistics for all variables for the total
sample. We then used logistic regression to examine the
relationship between the sociodemographic and cancer
worry variables, and FOBt screening intention and
uptake. In addition to the unadjusted associations, we
compared a series of logistic regression models containing
only the sociodemographic variables and ABACUS Wave
(Model 1) with four models adding cancer worry frequen-
cy (Model 2), cancer worry intensity (Model 3), both
(Model 4), or the combined measure of cancer worry
(Model 5). We used weighted data for descriptive analyses,
as sample weights are highly relevant for prevalence esti-
mation, but relied on unweighted data to test associations,
as weights typically do not alter the results of coefficients,
and unweighted analysis has been recommended because
of being simpler, more transparent, and more accurate
(e.g. reduced standard error, reduced risk of overfitting).38
As a sensitivity analysis, we also performed the same anal-
yses using the continuous cancer worry variables. For
these analyses, we also tested the interaction effect for
cancer worry frequency and intensity, and curvilinear
effects of cancer worry frequency and intensity on
screening intentions and uptake. Stata 12 SE was used
for all analyses and alpha levels of 0.05 or less indicated
statistical significance.
Results
The weighted sample characteristics for each wave and
for the combined sample are reported in Table 1 (the
unweighted sample characteristics are reported in Table
S1 in the Online Supplement). The mean age of the
sample was 65.2 (SD¼ 3.3), and 47% were men. Similar
to the general population estimates for this age group in
England,39 the majority of respondents were married or
living as married (67%) and of White ethnic origin
(95%). About a quarter of respondents (24%) came
from social grades D and E, 21% were in grade C2,
24% in grade C1, and 31% in grade A/B. Across all
four waves, 69% had participated in FOBt screening at
least once, and 81% intended to participate when
next invited.
In terms of frequency of worry about cancer, more than
a third (39%) never worried about getting cancer, nearly
half of the sample (49%) worried occasionally or some-
times, and a minority (5%) worried often or very often
(Table 1). In terms of cancer worry intensity, just over a
third (37%) did not feel anxious at all when thinking about
cancer, 40% were slightly anxious, and 20% were quite or
extremely anxious. When these two measures were com-
bined, 28% of the sample was classified as having “no
cancer worry,” 45% as having “moderate cancer worry,”
and 20% as having “high cancer worry.”
After excluding those with missing data on the cancer
worry and intention variables, a sample of N¼ 2463
remained for analysis (Table 2). Of these, 86% intended
to take the stool test when they were next invited. FOBt
screening intentions were significantly lower in those who
were single (79%) or those who were widowed, separated,
or divorced (83%), than in those who were married or
living as married (88%). There was also a significant
social gradient in screening intentions, with fewer of
those from lower social grades intending to do the FOBt
(C1: 87%, C2: 85%, DE: 81%) compared with those from
the highest social grade (AB: 92%), and these associations
remained significant when all other sociodemographic var-
iables were adjusted for in Model 1 (Table 2). Model 1
explained 4.2% of variance in the data.
We then compared Model 1 with the four models that
contained the sociodemographic variables as well as
cancer worry frequency (Model 2), cancer worry intensity
(Model 3), both (Model 4), or the combined cancer worry
measure (Model 5; see Table 2). All models explained sig-
nificantly more variance than Model 1 (Model 2 v2diff(2)¼
14.0, p< 0.001, Model 3 v2diff(2)¼28.3, p< 0.001, Model 4
v2diff(2)¼ 29.2, p< 0.001, and Model 5 v2diff(2)¼
15.8, p< 0.001).
Compared with never worrying, worrying about cancer
occasionally or sometimes was significantly and positively
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associated with FOBt screening intentions when all socio-
demographic variables were adjusted for (82% vs. 88%
reported positive intention; OR¼ 1.57, 95% CI 1.23–
1.99; Model 2), but there was no association with worrying
often or very often. Similarly, compared with not being
anxious (81% reported positive intention), reporting
slight vs. quite a bit or extreme cancer worry intensity
increased the odds of intending to do the FOBt (90%;
OR¼ 1.99, 95% CI 1.53–2.59; 87%; OR¼ 1.61, 95% CI
1.18–2.21, respectively; Model 3). When both measures
were combined in a single model (Model 4), cancer
worry frequency was no longer significantly associated
with FOBt screening intentions, but cancer worry intensity
remained significantly associated. For the combined mea-
sure (Model 5), both moderate and high levels of cancer
worry were significantly and positively associated with
FOBt screening intentions, but this model explained less
variance (Nagelkerke’s R2¼ .053) than Models 3 or 4
(Nagelkerke’s R2¼ .062 and .062, respectively). The differ-
ence between Models 3 and 4 was non-significant
(v2 diff(2)¼ 0.90, p¼ 0.64). Thus, Model 3 (cancer worry
intensity) appeared the most parsimonious.
Table 1. Weighted sample characteristics per wave and for the combined sample (N¼ 2878).
ABACUS 1 ABACUS 2 ABACUS 3 ABACUS 4 TOTAL
N¼1381 N¼719 N¼369 N¼409 N¼2878
Age (mean and SD) 65.14 (3.20) 65.06 (3.19) 65.58 (3.27) 65.34 (3.47) 65.21 (3.25)
Gender: n (%)
Male 701 (45.7%) 353 (48.7%) 201 (50.1%) 200 (46.2%) 1455 (47.1%)
Female 680 (54.3%) 366 (51.3%) 168 (49.9%) 209 (53.8%) 1423 (52.9%)
Ethnicity: n (%)
White 1316 (96.1%) 681 (94.5%) 346 (94.5%) 385 (93.8%) 2728 (95.2%)
Other 65 (3.9%) 38 (5.5%) 23 (5.5%) 24 (6.2%) 150 (4.8%)
Marital status: n (%)
Married or living
as married
901 (69.7%) 442 (64.7%) 236 (66.7%) 254 (64.8%) 1833 (67.4%)
Single 122 (7.4%) 78 (10.2%) 50 (11.7%) 47 (10.8%) 297 (9.1%)
Widowed, separated
or divorced
358 (22.9%) 199 (25.1%) 83 (21.6%) 108 (24.4%) 748 (23.5%)
Social grade: n (%)
A/B 347 (30.9%) 153 (31.3%) 85 (31.1%) 84 (31.3%) 669 (31.1%)
C1 301 (26.5%) 142 (21.6%) 81 (23.2%) 91 (21.6%) 615 (24.2%)
C2 255 (21.4%) 152 (23.0%) 60 (16.4%) 43 (17.8%) 510 (20.7%)
D/E 478 (21.2%) 272 (24.1%) 143 (29.3%) 161 (29.3%) 1054 (24.0%)
Cancer worry frequency: n (%)
Never 484 (32.9%) 360 (49.2%) 142 (36.4%) 176 (42.6%) 1162 (38.7%)
Occasionally 382 (28.6%) 237 (34.7%) 150 (42.0%) 145 (36.4%) 914 (32.8%)
Sometimes 257 (19.5%) 80 (10.5%) 57 (16.2%) 63 (15.4%) 457 (16.3%)
Often 66 (5.1%) 12 (1.4%) 8 (2.3%) 11 (2.6%) 97 (3.5%)
Very often 21 (1.5%) 6 (0.8%) 3 (0.9%) 4 (0.8%) 34 (1.2%)
Missing 171 (12.3%) 24 (3.4%) 9 (2.4%) 10 (2.3%) 214 (7.5%)
Cancer worry intensity: n (%)
Not at all 461 (32.3%) 315 (43.7%) 138 (36.1%) 165 (39.7%) 1079 (36.6%)
Slightly 511 (38.4%) 283 (39.9%) 164 (46.4%) 172 (43.3%) 1130 (40.4%)
Quite 244 (18.4%) 75 (10.4%) 38 (9.6%) 51 (12.4%) 408 (14.5%)
Extremely 110 (7.6%) 18 (2.3%) 19 (5.4%) 11 (2.4%) 158 (5.3%)
Missing 55 (3.4%) 28 (3.7%) 10 (2.5%) 10 (2.2%) 103 (3.2%)
Cancer worry (combined measure): n (%)
No worry 323 (21.8%) 267 (37.1%) 103 (26.8%) 130 (31.1%) 823 (27.5%)
Moderate worry 545 (41.2%) 322 (45.3%) 196 (55.1%) 203 (50.8%) 1266 (45.2%)
High worry 328 (23.8%) 93 (12.7%) 57 (15.0%) 65 (15.7%) 543 (18.9%)
Missing 185 (13.2%) 37 (4.9%) 13 (3.2%) 11 (2.4%) 246 (8.5%)
Uptake: n (%)
No 214 (14.7%) 122 (16.1%) 106 (27.0%) 112 (26.5%) 554 (18.3%)
Yes 913 (68.2%) 480 (68.3%) 252 (70.5%) 273 (68.1%) 1918 (68.5%)
Missing 254 (17.1%) 117 (16.6%) 11 (2.6%) 24 (5.4%) 406 (13.2%)
Screening intentions: n (%)
No 180 (12.3%) 105 (14.1%) 58 (12.9%) 48 (10.3%) 391 (12.6%)
Yes 1076 (79.7%) 555 (79.3%) 298 (82.6%) 334 (83.8%) 2263 (80.5%)
Missing 125 (8.0%) 59 (6.6%) 20 (4.5%) 27 (5.9%) 231 (6.9%)
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After excluding those with missing data on the cancer
worry and uptake variables, a sample of N¼ 2318
remained for analysis (Table 3). Overall, 78% of respond-
ents reported having done the stool test at least once.
Cancer screening uptake was significantly and positively
associated with age. Self-reported past FOBt uptake was
significantly lower in those who were single (63%) com-
pared with those who were married or living as married
(80%), and in those from lower social grades (C2: 78%,
DE: 72%) compared with those from the highest social
grade (AB: 83%). These associations remained significant
when all other sociodemographic variables were adjusted
for in Model 1 (Table 3). Model 1 explained 5.8% of the
variance in the data.
We then compared Model 1 with the other four models.
Model 3 (v2diff(2)¼16.5, p< 0.001), Model 4 (v2diff(2)¼20.0,
p< 0.001), and Model 5 (v2diff(2)¼7.79, p¼0.02) explained
significantly more variance than Model 1, but Model 2 did
not (v2diff(2)¼2.57, p¼0.28), i.e. cancer worry frequency
was not associated with self-reported past uptake of
FOBt (Table 3). In Model 3, compared with not being
anxious at all (73% uptake), being slightly, or quite a bit
or extremely anxious about cancer was associated with
increased odds of FOBt uptake (81%; OR¼ 1.52, 95%
CI 1.21–1.89; and 81%; OR¼ 1.55, 95% CI 1.16–2.05,
respectively). Cancer worry frequency was not significantly
associated with FOBt uptake in Model 4 when cancer
worry intensity was also included in the model. For the
combined cancer worry measure, moderate and high levels
of worry were significantly associated with FOBt screening
uptake (Model 5), but this model explained less variance
than Models 3 and 4, which again explained most variance
(Nagelkerke’s R2¼.068 and .070, respectively). There was
no difference between these models in the amount of var-
iance explained (v2diff(2)¼3.49, p¼0.18). Thus, Model 3
(cancer worry intensity) again appeared the most
parsimonious.
We repeated all analyses using the continuous cancer
worry variables and an interaction term for cancer worry
frequency and intensity to test their additive effects. We
also tested for curvilinear effects in these analyses. The full
results are reported in the Online Supplement. Briefly,
both cancer worry frequency and intensity were signifi-
cantly associated with FOBt screening intentions, both lin-
early and curvilinearly (Online Supplement Table S2).
When both were combined into a single model, either sep-
arately or their interaction, only cancer worry intensity
remained significantly associated with screening inten-
tions, while the variance explained increased only margin-
ally compared with a model with only cancer worry
intensity (R2¼.066 vs. R2¼.065). The results were very
similar for self-reported FOBt screening uptake (Table 2,
and Online Supplement Table S3). The results from these
sensitivity analyses therefore also suggest that the most
parsimonious model of FOBt screening intentions and
uptake is one with cancer worry intensity.
Discussion
This study found that being at least slightly and at least
occasionally worried about cancer was relatively common,
with nearly two out of three people being either moderate-
ly or very worried on the measure that combined frequen-
cy and intensity of cancer worry. A comparison of the two
measures indicated that respondents did not necessarily
worry about cancer often, but that many experienced mod-
erate to high levels of worry when they thought about it.
Furthermore, it was this level of cancer worry intensity,
rather than the frequency of worrying, that seemed to be
associated with CRC screening intention and uptake. Our
findings therefore seem to suggest that, contrary to
common practice, a single item on cancer worry intensity
rather than frequency could be used when trying to explain
variance in uptake of colorectal cancer screening.
This is the first study of FOBt screening in the UK to
include measures of both cancer worry frequency and
intensity. It is also the first study to explicitly examine
which of these measures is more strongly associated with
intentions and with (self-reported) screening uptake.
It should be noted that previous research did not just
find differences between different aspects of cancer worry,
but also important inconsistencies according to screening
modality (FOBt vs. endoscopic screening), programme
(cervical vs. breast vs. colorectal), population (US vs.
UK vs. Singapore), and whether measures of screening
intentions or uptake are used. For this reason, it is difficult
to make strong claims about the practical implications of
the findings. Future research should investigate psycholog-
ical antecedents of cancer worry intensity. While simply
increasing worry about cancer would be potentially uneth-
ical and an inappropriate way to increase engagement with
cancer screening, it is possible that what underlies our
observation relates to more general perceptions of
cancer, or indeed cancer screening (e.g. lack of perceived
risk and optimistic bias), which could be addressed
without necessarily ‘scaring’ people into attending
cancer screening.
The sociodemographic patterns in FOBt screening
intentions and uptake in our study were similar to previous
studies,6,7 with intentions and uptake lower in those from
more deprived backgrounds and those who are single.
Screening intentions and uptake were also lower in those
from non-White ethnic backgrounds, although these dif-
ferences were not significant in our study. Our study may
have been underpowered to detect these differences due to
the small percentage of those from a non-White ethnic
background in our sample (5%), which is nevertheless con-
sistent with the ethnic distribution for this age group.39 As
would be expected, we found a small but statistically sig-
nificant positive association between age and ‘ever’ having
done the FOB test, as those who are older would have
received more invitations to complete the test, but we
did not find an association between age and intentions to
do the test when next invited. Self-reported ‘ever’ uptake
of the FOBt (69%) was similar to self-reported ever uptake
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in other studies in the UK (70%),37,40 and has been shown
to be highly consistent with actual uptake of FOBt
screening.37
This study had some limitations. It is the first study to
suggest that cancer worry intensity, rather than frequency,
may be more strongly associated with uptake of screening
for colorectal cancer, although these constructs were mea-
sured using single items that have inherent validity
problems, and face validity was the only accessible psycho-
metric property of the measures used in the current study.
More work is needed to validate measures of cancer worry
frequency and intensity, and future studies should try to
replicate our findings to see if measures of cancer worry in
large population-based studies should be changed from
frequency to intensity items. We note that the single item
measure relating to cancer worry in the US HINTS has
already been changed from a frequency to an intensity-
based item from the 2003, 2005, and 2008 to the 2011–
2013 and 2017 surveys.33 The questions about cancer
worry frequency and cancer worry intensity were about
cancer in general, not specifically about colorectal
cancer. This may have affected the strength of the associ-
ations, as previous research shows that attitudes may differ
between cancer types,5,41 and future studies should use
measures specific to colorectal cancer. In addition, few
people scored the highest two levels of cancer worry fre-
quency (often and very often). We therefore chose to col-
lapse these categories, but the small sample size, even in
the collapsed category, may have limited the power to
detect any effects of frequent cancer worry on screening
intention and uptake, and future studies may wish to over-
sample these levels of cancer worry frequency to formally
test these associations. A further limitation is that this
study only measured intensity and frequency of cancer
worry, while various literature reviews of cancer worry in
the general population suggest that there may be a variety
of sources of cancer worry that may have different behav-
ioural effects.8,25,26 In our recent review of the qualitative
literature, we provide a comprehensive taxonomy of
cancer worries related to cancer screening, including
cancer worry as a general and diffuse worry, and worries
about specific aspects of cancer, such as treatment, death,
or the social consequences of a diagnosis.25 A recent
population-based survey of self-reported cancer screening
uptake found differential behavioural associations by type
of cancer worry,30 and future studies should therefore
include more comprehensive measures of cancer worry
whenever possible. Items used to assess general feelings
of cancer worry, such as those used in the current study,
may nevertheless give a meaningful general overview of
whether the cancer worry emotion tends to favour
uptake of a particular type of screening or not.
Furthermore, excluding people with missing data intro-
duced a certain amount of selection bias, as indicated by
the level of intention and uptake in the final analytic
sample (86% and 77% respectively). We adjusted for the
effect of sociodemographic confounders, but there may be
other confounding variables, such as family history of
colorectal cancer and physician recommendation, that
may influence the association between cancer worry and
screening uptake, and could be included in future studies.
Finally, due to the cross-sectional nature of the study, it is
not possible to draw any conclusions about the causal
nature of the relationships or their temporal development.
Prospective, longitudinal studies could examine how
cancer worry frequency and intensity develop over time
and in response to screening attendance.
Conclusion
This large cross-sectional analysis was the first to compare
cancer worry frequency versus cancer worry intensity in
the context of CRC screening. Our findings suggest that
cancer worry intensity, rather than frequency, is informa-
tive when understanding engagement with CRC screening
using gFOBt. Future studies should use prospective
designs and objective uptake across different CRC screen-
ing modalities, and other cancer screening programmes.
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